References

  1. Alberti, S., Schuster, G., Parini, P., Feltkamp, D., Diczfalusy, U., Rudling, M., Angelin, B., Bjorkhem, I., Pettersson, S., and Gustafsson, J A. 2001. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107(5): 565-573.
  2. Aldridge, T.C., Tugwood, J.D., and Green, S. 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem J 306(Pt 2): 473-479.
  3. Alroy, I., Towers, T.L., and Freedman, L.P. 1995. Transcriptional repression of the inter-leukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15(10): 5789-5799.
  4. Araya, Z. and Wikvall, K. 1999. 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta 1438(1): 47-54.
  5. Archer, A., Sauvaget, D., Chauffeton, V., Bouchet, P.E., Chambaz, J., Pincon-Raymond, M., Cardot, P., Ribeiro, A., and Lacasa, M. 2005. Intestinal apolipoprotein A-IV gene transcription is controlled by two hormone-responsive elements: a role for hepatic nuclear factor-4 isoforms. Mol Endocrinol 19(9): 2320-2334.
  6. Baes, M., Gulick, T., Choi, H.S., Martinoli, M.G., Simha, D., and Moore, D.D. 1994. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14(3): 1544-1552.
  7. Bahar, R.J. and Stolz, A. 1999. Bile acid transport. Gastroenterol Clin North Am 28(1): 27-58.
  8. Baidya, S.G. and Zeng, Q.T. 2005. Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J 81(962): 746-752.
  9. Baker, K.D., Shewchuk, L.M., Kozlova, T., Makishima, M., Hassell, A., Wisely, B., Caravella, J.A., Lambert, M.H., Reinking, J.L., Krause H., Thummel, C.S., Willson, T.M., and Mangelsdort, D.J. 2003. The Drosophila orphan nuclear receptor DHR38 mediates an a typical ecdysteriod signalling pathway. Cell 113(6): 731-742.
  10. Barak, Y., Liao, D., He, W., Ong, E.S., Nelson, M.C., Olefsky, J.M., Boland, R., and Evans, R.M. 2002. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A 99(1): 303-308.
  11. Barak, Y., Nelson, M.C., Ong, E.S., Jones, Y.Z., Ruiz-Lozano, P., Chien, K.R., Koder, A., and Evans, R.M. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4(4): 585-595.
  12. Barnes, P.J. and Karin, M. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336(15): 1066-1071.
  13. Barter, P. 2000. CETP and atherosclerosis. Arterioscler Thromb Vasc Biol 20(9): 2029-2031.
  14. Bellosta, S., Mahley, R.W., Sanan, D.A., Murata, J., Newland, D.L., Taylor, J.M., and Pitas, R.E. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest 96(5): 2170-2179.
  15. Berg, J.M. 1989. DNA binding specificity of steroid receptors. Cell 57(7): 1065-1068.
  16. Bettoun, D.J., Burris, T.P., Houck, K.A., Buck, D.W., 2nd, Stayrook, K.R., Khalifa, B., Lu, J., Chin, W.W., and Nagpal, S. 2003. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol Endocrinol 17(11): 2320-2328.
  17. Bjornheden, T., Babyi, A., Bondjers, G., and Wiklund, O. 1996. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 123(1-2): 43-56.
  18. Blanco, J.C., Dey, A., Leid, M., Minucci, S., Park, B.K., Jurutka, P.W., Haussler, M.R., and Ozato, K. 1996. Inhibition of ligand induced promoter occupancy in vivo by a dominant negative RXR. Genes Cells 1(2): 209-221.
  19. Bogan, A.A., Dallas-Yang, Q., Ruse, M.D., Jr., Maeda, Y., Jiang, G., Nepomuceno, L., Scanlan, T.S., Cohen, F.E., and Sladek, F.M. 2000. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha. J Mol Bio 302(4): 831-851.
  20. Boj, S.F., Parrizas, M., Maestro, M.A., and Ferrer, J. 2001. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A 98(25): 14481-14486.
  21. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137(1): 354-366.
  22. Cao, G., Beyer, T.P., Yang, X.P., Schmidt, R.J., Zhang, Y., Bensch, W.R., Kauffman, R.F., Gao, H., Ryan, T.P., Liang, Y., Eacho, P.I., and Jiang, X.C. 2002. Phospholipid transfer protein is regulated by liver X receptors in vivo. J Biol Chem 277(42): 39561-39565.
  23. Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T.H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.C., Gonzalez, F.J., Kuipers, F., and Staels, B. 2006. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281(16): 11039-11049.
  24. Castelli, W.P., Garrison, R.J., Wilson, P.W., Abbott, R.D., Kalousdian, S., and Kannel, W.B. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256(20): 2835-2838.
  25. Chartier, F.L., Bossu, J.P., Laudet, V., Fruchart, J.C., and Laine, B. 1994. Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene 147(2): 269-272.
  26. Chawla, A., Boisvert, W.A., Lee, C.H., Laffitte, B.A., Barak, Y., Joseph, S.B., Liao, D., Nagy, L., Edwards, P.A., Curtiss, L.K., Evans, R.M., and Tontonoz, P. 2001. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and athero-genesis. Mol Cell 7(1): 161-171.
  27. Chiang, J.Y., Kimmel, R., and Stroup, D. 2001. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 262(1-2): 257-265.
  28. Cippitelli, M. and Santoni, A. 1998. Vitamin D3: a transcriptional modulator of the inter-feron-gamma gene. Eur J Immunol 28(10): 3017-3030.
  29. Costet, P., Luo, Y., Wang, N., and Tall, A.R. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275(36): 28240-28245.
  30. Crestani, M., Sadeghpour, A., Stroup, D., Galli, G., and Chiang, J.Y. 1998. Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. J Lipid Res 39(11): 2192-2200.
  31. Curtiss, L.K. and Boisvert, W.A. 2000. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 11(3): 243-251.
  32. De Fabiani, E., Mitro, N., Anzulovich, A.C., Pinelli, A., Galli, G., and Crestani, M. 2001. The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276(33): 30708-30716.
  33. Denson, L.A., Sturm, E., Echevarria, W., Zimmerman, T.L., Makishima, M., Mangelsdorf, D.J., and Karpen, S.J. 2001. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121(1): 140-147.
  34. Desvergne, B. and Wahli, W. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20(5): 649-688.
  35. Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G., and Wahli, W. 1993. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxi-some proliferator-activated receptors (PPAR). Biol Cell 77(1): 67-76.
  36. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., and Wahli, W. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68(5): 879-887.
  37. Drocourt, L., Ourlin, J.C., Pascussi, J.M., Maurel, P., and Vilarem, M.J. 2002. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277(28): 25125-25132.
  38. Du, X., Tabeta, K., Mann, N., Crozat, K., Mudd, S., and Beutler, B. 2005. An essential role for Rxr alpha in the development of Th2 responses. Eur J Immunol 35(12): 3414-3423.
  39. Echchgadda, I., Song, C.S., Roy, A.K., and Chatterjee, B. 2004. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65(3): 720-729.
  40. Eeckhoute, J., Formstecher, P., and Laine, B. 2004. Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription. Nucleic Acids Res 32(8): 2586-2593.
  41. Efanov, A.M., Barrett, D.G., Brenner, M.B., Briggs, S.L., Delaunois, A., Durbin, J.D., Giese, U., Guo, H., Radloff, M., Gil, G.S., Sewing, S., Wang, Y., Weichert, A., Zaliani, A., and Gromada, J. 2005. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 146(9): 3696-3701.
  42. Escriva, H., Delaunay, F., and Laudet, V. 2000. Ligand binding and nuclear receptor evolution. Bioessays 22(8): 717-727.
  43. Escriva, H., Safi, R., Hanni, C., Langlois, M.C., Saumitou-Laprade, P., Stehelin, D., Capron, A., Pierce, R., and Laudet, V. 1997. Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci U S A 94(13): 6803-6808.
  44. Foger, B., Santamarina-Fojo, S., Shamburek, R.D., Parrot, C.L., Talley, G.D., and Brewer, H.B., Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem 272(43): 27393-27400.
  45. Forman, B.M. 2005. Are those phospholipids in your pocket? Cell Metab 1(3): 153-155.
  46. Forman, B.M., Chen, J., and Evans, R.M. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A 94(9): 4312-4317.
  47. Forman, B.M., Goode, E., Chen, J., Oro, A.E., Bradley, D.J., Perlmann, T., Noonan, D.J., Burka, L.T., McMorris, T., Lamph, W.W., Evans, R.M., and Weinberger, C. 1995a. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81(5): 687-693.
  48. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., and Evans, R.M. 1995b. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83(5): 803-812.
  49. Forman, B.M., Tzameli, I., Choi, H.S., Chen, J., Simha, D., Seol, W., Evans, R.M., and Moore, D.D. 1998. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395(6702): 612-615.
  50. Forman, B.M., Umesono, K., Chen, J., and Evans, R.M. 1995c. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81(4): 541-550.
  51. Goldberg, I.J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37(4): 693-707.
  52. Goodwin, B., Jones, S.A., Price, R.R., Watson, M.A., McKee, D.D., Moore, L.B., Galardi, C., Wilson, J.G., Lewis, M.C., Roth, M.E., Maloney, P.R., Willson, T.M., and Kliewer, S.A. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6(3): 517-526.
  53. Graham, T.L., Mookherjee, C., Suckling, K.E., CN, A.P., and Patel, L. 2005. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis 181(1): 29-37.
  54. Grefhorst, A., van Dijk, T.H., Hammer, A., van der Sluijs, F.H., Havinga, R., Havekes, L.M., Romijn, J.A., Groot, P.H., Reijngoud, D.J., and Kuipers, F. 2005. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol 289(5): E829-838.
  55. Grimes, D.S., Hindle, E., and Dyer, T. 1996. Sunlight, cholesterol and coronary heart disease. QJM 89(8): 579-589.
  56. Grober, J., Zaghini, I., Fujii, H., Jones, S.A., Kliewer, S.A., Willson, T.M., Ono, T., and Besnard, P. 1999. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor het-erodimer. J Biol Chem 274(42): 29749-29754.
  57. Gulick, T., Cresci, S., Caira, T., Moore, D.D., and Kelly, D.P. 1994. The peroxisome prolif-erator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci U S A 91(23): 11012-11016.
  58. Hayhurst, G.P., Lee, Y.H., Lambert, G., Ward, J.M., and Gonzalez, F.J. 2001. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21(4): 1393-1403.
  59. He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J.M., and Evans, R.M. 2003. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 100(26): 15712-15717.
  60. Hebuterne, X., Wang, X.D., Johnson, E.J., Krinsky, N.I., and Russell, R.M. 1995. Intestinal absorption and metabolism of 9-cis-beta-carotene in vivo: biosynthesis of 9-cis-retinoic acid. J Lipid Res 36(6): 1264-1273.
  61. Hertz, R., Magenheim, J., Berman, I., and Bar-Tana, J. 1998. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392(6675): 512-516.
  62. Hevener, A.L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R.M., and Olefsky, J. 2003. Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9(12): 1491-1497.
  63. Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M., and Thaller, C. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68(2): 397-406.
  64. Hirohashi, T., Suzuki, H., and Sugiyama, Y. 1999. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274(21): 15181-15185.
  65. Hollenberg, S.M., Weinberger, C., Ong, E.S., Cerelli, G., Oro, A., Lebo, R., Thompson, E.B., Rosenfeld, M.G., and Evans, R.M. 1985. Primary structu re and expression of a functional human glucocorticoid receptor cDNA. Nature 318(6047): 635-641.
  66. Holt, J.A., Luo, G., Billin, A.N., Bisi, J., McNeill, Y.Y., Kozarsky, K.F., Donahee, M., Wang, D.Y., Mansfield, T.A., Kliewer, S.A., Goodwin, B., and Jones, S.A. 2003. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17(13): 1581-1591.
  67. Honkakoski, P., Moore, R., Washburn, K.A., and Negishi, M. 1998a. Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol Pharmacol 53(4): 597-601.
  68. Honkakoski, P., Zelko, I., Sueyoshi, T., and Negishi, M. 1998b. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18(10): 5652-5658.
  69. Huang, W., Zhang, J., Chua, S.S., Qatanani, M., Han, Y., Granata, R., and Moore, D.D. 2003. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A 100(7): 4156-4161.
  70. Hunt, A.N., Clark, G.T., Attard, G.S., and Postle, A.D. 2001. Highly saturated endonuclear phosphatidylcholine is synthesized in situ and colocated with CDP-choline pathway enzymes. J Biol Chem 276(11): 8492-8499.
  71. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C.L., McDonald, J.G., Luo, G., Jones, S.A., Goodwin, B., Richardson, J.A., Gerard, R.D., Repa, J.J., Mangelsdorf, D.J., and Kliewer, S.A. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2(4): 217-225.
  72. Issemann, I. and Green, S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347(6294): 645-650.
  73. Iwata, M., Eshima, Y., and Kagechika, H. 2003. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15(8): 1017-1025.
  74. Jaari, S., van Dijk, K.W., Olkkonen, V.M., van der Zee, A., Metso, J., Havekes, L., Jauhiainen, M., and Ehnholm, C. 2001. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation. Comp Biochem Physiol 128(4): 781-792.
  75. Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R., and Mangelsdorf, D.J. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383(6602): 728-731.
  76. Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J., and Tontonoz, P. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9(2): 213-219.
  77. Karin, M. 1998. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93(4): 487-490.
  78. Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., and Negishi, M. 1999. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19(9): 6318-6322.
  79. Kerr, T.A., Saeki, S., Schneider, M., Schaefer, K., Berdy, S., Redder, T., Shan, B., Russell, D.W., and Schwarz, M. 2002. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2(6): 713-720.
  80. Kersten, S., Seydoux, J., Peters, J.M., Gonzalez, F.J., Desvergne, B., and Wahli, W. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103(11): 1489-1498.
  81. Kliewer, S.A., Lenhard, J.M., Willson, T.M., Patel, I., Morris, D.C., and Lehmann, J.M. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83(5): 813-819.
  82. Kliewer, S.A., Moore, J.T., Wade, L., Staudinger, J.L., Watson, M.A., Jones, S.A., McKee, D.D., Oliver, B.B., Willson, T.M., Zetterstrom, R.H., Perlmann, T., and Lehmann, J.M. 1998. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92(1): 73-82.
  83. Kliewer, S.A., Sundseth, S.S., Jones, S.A., Brown, P.J., Wisely, G.B., Koble, C.S., Devchand, P., Wahli, W., Willson, T.M., Lenhard, J.M., and Lehmann, J.M. 1997. Fatty acids and eicosa-noids regulate gene expression through direct interactions with peroxisome proliferator-acti-vated receptors alpha and gamma. Proc Natl Acad Sci U S A 94(9): 4318-4323.
  84. Klug, A. and Schwabe, J.W. 1995. Protein motifs 5. Zinc fingers. Faseb J 9(8): 597-604.
  85. Koelle, M.R., Talbot, W.S., Segraves, W.A., Bender, M.T., Cherbas, P., and Hogness, D.S. 1991. The Drosophila EcR gene encodes an ecdysone receptor, a new member of the steroid receptor superfamily. Cell 67(1): 59-77.
  86. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M.G., and Wahli, W. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxi-some proliferator-activated receptors by coactivator- dependent receptor ligand assay. Mol Endocrinol 11(6): 779-791.
  87. Krylova, I.N., Sablin, E.P., Moore, J., Xu, R.X., Waitt, G.M., MacKay, J.A., Juzumiene, D., Bynum, J.M., Madauss, K., Montana, V., Lebedeva, L., Suzawa, M., Williams, J.D., Williams,S.P., Guy, R.K., Thornton, J.W., Fletterick, R.J., Willson, T.M., and Ingraham, H. A. 2005. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120(3): 343-355.
  88. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., Eto, K., Tsubamoto, Y., Okuno, A., Murakami, K., Sekihara, H., Hasegawa, G., Naito, M., Toyoshima, Y., Tanaka, S., Shiota, K., Kitamura, T., Fujita, T., Ezaki, O., Aizawa, S., Kadowaki, T., et al. 1999. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4(4): 597-609.
  89. Kuo, L.C. and Makinen, M.W. 1982. Hydrolysis of esters by carboxypeptidase A requires a penta-coordinate metal ion. J Biol Chem 257(1): 24-27.
  90. Ladias, J.A., Hadzopoulou-Cladaras, M., Kardassis, D., Cardot, P., Cheng, J., Zannis, V., and Cladaras, C. 1992. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem 267(22): 15849-15860.
  91. Laffitte, B.A., Joseph, S.B., Chen, M., Castrillo, A., Repa, J., Wilpitz, D., Mangelsdorf, D., and Tontonoz, P. 2003. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol 23(6): 2182-2191.
  92. Laffitte, B.A., Repa, J.J., Joseph, S.B., Wilpitz, D.C., Kast, H.R., Mangelsdorf, D.J., and Tontonoz, P. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A 98(2): 507-512.
  93. Lavrentiadou, S.N., Hadzopoulou-Cladaras, M., Kardassis, D., and Zannis, V.I. 1999. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. Biochemistry 38(3): 964-975.
  94. Lee, C.H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W.A., Evans, R.M., and Curtiss, L.K. 2003. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302(5644): 453-457.
  95. Lee, C.H., Kang, K., Mehl, I.R., Nofsinger, R., Alaynick, W.A., Chong, L.W., Rosenfeld, J.M., and Evans, R.M. 2006a. Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage. Proc Natl Acad Sci U S A 103(7): 2434-2439.
  96. Lee, C.H., Olson, P., Hevener, A., Mehl, I., Chong, L.W., Olefsky, J.M., Gonzalez, F.J., Ham, J., Kang, H., Peters, J.M., and Evans, R.M. 2006b. PPARjdeltaj regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A.
  97. Lehmann, J.M., Kliewer, S.A., Moore, L.B., Smith-Oliver, T.A., Oliver, B.B., Su, J.L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A., and Willson, T.M. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272(6): 3137-3140.
  98. Lehto, M., Bitzen, P.O., Isomaa, B., Wipemo, C., Wessman, Y., Forsblom, C., Tuomi, T., Taskinen, M.R., and Groop, L. 1999. Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism. Diabetes 48(2): 423-425.
  99. Lemberger, T., Saladin, R., Vazquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., and Auwerx, J. 1996. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 271(3): 1764-1769.
  100. Leone, T.C., Weinheimer, C.J., and Kelly, D.P. 1999. A critical role for the peroxisome prolif-erator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96(13): 7473-7478.
  101. Levin, A.A., Sturzenbecker, L.J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., Lovey, A., and et al. 1992. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 355(6358): 359-361.

102 Li, A.C., Brown, K.K., Silvestre, M.J., Willson, T.M., Palinski, W., and Glass, C.K. 2000. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106(4): 523-531.

  1. Li, Y., Choi, M., Cavey, G., Daugherty, J., Suino, K., Kovach, A., Bingham, N.C., Kliewer, S.A., and Xu, H.E. 2005. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17(4): 491-502.
  2. Linton, M.F., Atkinson, J.B., and Fazio, S. 1995. Prevention of atherosclerosis in apolipopro-tein E-deficient mice by bone marrow transplantation. Science 267(5200): 1034-1037.
  3. Lu, T.T., Makishima, M., Repa, J.J., Schoonjans, K., Kerr, T.A., Auwerx, J., and Mangelsdorf, D.J. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6(3): 507-515.
  4. Luo, Y. and Tall, A.R. 2000. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest 105(4): 513-520.
  5. Luquet, S., Lopez-Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., and Grimaldi, P.A. 2003. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. Faseb J 17(15): 2299-2301.
  6. Ma, K., Saha, P.K., Chan, L., and Moore, D.D. 2006. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 116(4): 1102-1109.
  7. Mak, P.A., Laffitte, B.A., Desrumaux, C., Joseph, S.B., Curtiss, L.K., Mangelsdorf, D.J., Tontonoz, P., and Edwards, P.A. 2002. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem 277(35): 31900-31908.
  8. Makishima, M., Lu, T.T., Xie, W., Whitfield, G.K., Domoto, H., Evans, R.M., Haussler, M.R., and Mangelsdorf, D.J. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science 296(5571): 1313-1316.
  9. Makishima, M., Okamoto, A.Y., Repa, J.J., Tu, H., Learned, R.M., Luk, A., Hull, M.V., Lustig, K.D., Mangelsdorf, D.J., and Shan, B. 1999. Identification of a nuclear receptor for bile acids. Science 284(5418): 1362-1365.
  10. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. 1995. The nuclear receptor super-family: the second decade. Cell 83(6): 835-839.
  11. McCarthy, T.C., Li, X., and Sinal, C.J. 2005. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280(24): 23232-23242.
  12. Mertz, J.R., Shang, E., Piantedosi, R., Wei, S., Wolgemuth, D.J., and Blaner, W.S. 1997. Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. A possible role in 9-cis-retinoic acid formation. J Biol Chem 272(18): 11744-11749.
  13. Miesfeld, R., Okret, S., Wikstrom, A.C., Wrange, O., Gustafsson, J.A., and Yamamoto, K.R. 1984. Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature 312(5996): 779-781.
  14. Mietus-Snyder, M., Sladek, F.M., Ginsburg, G.S., Kuo, C.F., Ladias, J.A., Darnell, J.E., Jr., and Karathanasis, S.K. 1992. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol 12(4): 1708-1718.
  15. Mitro, N., Mak, P.A., Vargas, L., Godio, C., Hampton, E., Molteni, V., Kreusch, A., and Saez, E. 2007. The nuclear receptor LXR is a glucose sensor. Nature 445(7124): 219-223.
  16. Mortimer, E.A., Jr., Monson, R.R., and MacMahon, B. 1977. Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 296(11): 581-585.
  17. Muerhoff, A.S., Griffin, K.J., and Johnson, E.F. 1992. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxy-lase, by clofibric acid. J Biol Chem 267(27): 19051-19053.
  18. Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L., and Kraus, W.E. 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem 277(29): 26089-26097.
  19. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H., and Evans, R.M. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93(2): 229-240.
  20. Nakamura, K., Kennedy, M.A., Baldan, A., Bojanic, D.D., Lyons, K., and Edwards, P.A. 2004. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J Biol Chem 279(44): 45980-45989.
  21. Nishimura, T., Utsunomiya, Y., Hoshikawa, M., Ohuchi, H., and Itoh, N. 1999. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1444(1): 148-151.
  22. Nissinen, M.J., Gylling, H., Jarvinen, H.J., and Miettinen, T.A. 2004. Ileal pouch-anal anastomosis, conventional ileostomy and ileorectal anastomosis modify cholesterol metabolism. Digest Dis Sci 49(9): 1444-1453.
  23. Nordestgaard, B.G. and Zilversmit, D.B. 1989. Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences. Arteriosclerosis 9(2): 176-183.
  24. Nuclear Receptors Nomenclature Committee. 1999. A unified nomenclature system for the nuclear receptor superfamily. Cell 97(2): 161-163.
  25. Oliveira, H.C., Ma, L., Milne, R., Marcovina, S.M., Inazu, A., Mabuchi, H., and Tall, A.R. 1997. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler Thromb Vasc Biol 17(6): 1045-1052.
  26. Oliver, W.R., Jr., Shenk, J.L., Snaith, M.R., Russell, C.S., Plunket, K.D., Bodkin, N.L., Lewis, M.C., Winegar, D.A., Sznaidman, M.L., Lambert, M.H., Xu, H.E., Sternbach, D.D., Kliewer, S.A., Hansen, B.C., and Willson, T.M. 2001. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98(9): 5306-5311.
  27. Ortlund, E.A., Lee, Y., Solomon, I.H., Hager, J.M., Safi, R., Choi, Y., Guan, Z., Tripathy, A., Raetz, C.R., McDonnell, D.P., Moore, D.D., and Redinbo, M.R. 2005. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat Struct Mol Biol 12(4): 357-363.
  28. Otte, K., Kranz, H., Kober, I., Thompson, P., Hoefer, M., Haubold, B., Remmel, B., Voss, H., Kaiser, C., Albers, M., Cheruvallath, Z., Jackson, D., Casari, G., Koegl, M., Paabo, S., Mous, J., Kremoser, C., and Deuschle, U. 2003. Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Mol Cell Biol 23(3): 864-872.
  29. Ou, J., Tu, H., Shan, B., Luk, A., DeBose-Boyd, R.A., Bashmakov, Y., Goldstein, J.L., and Brown, M.S. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A 98(11): 6027-6032.
  30. Overbergh, L., Decallonne, B., Valckx, D., Verstuyf, A., Depovere, J., Laureys, J., Rutgeerts, O., Saint-Arnaud, R., Bouillon, R., and Mathieu, C. 2000. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120(1): 139-146.
  31. Owen, K. and Hattersley, A.T. 2001. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 15(3): 309-323.
  32. Pare, J.F., Malenfant, D., Courtemanche, C., Jacob-Wagner, M., Roy, S., Allard, D., and Belanger, L. 2004. The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element. J Biol Chem 279(20): 21206-21216.
  33. Parks, D.J., Blanchard, S.G., Bledsoe, R.K., Chandra, G., Consler, T.G., Kliewer, S.A., Stimmel, J.B., Willson, T.M., Zavacki, A.M., Moore, D.D., and Lehmann, J.M. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284(5418): 1365-1368.
  34. Peet, D.J., Turley, S.D., Ma, W., Janowski, B.A., Lobaccaro, J.M., Hammer, R.E., and Mangelsdorf, D.J. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93(5): 693-704.
  35. Pei, L., Waki, H., Vaitheesvaran, B., Wilpitz, D.C., Kurland, I.J., and Tontonoz, P. 2006. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12(9): 1048-1055.
  36. Peters, J.M., Hennuyer, N., Staels, B., Fruchart, J.C., Fievet, C., Gonzalez, F.J., and Auwerx, J. 1997. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J Biol Chem 272(43): 27307-27312.
  37. Peters, J.M., Lee, S.S., Li, W., Ward, J.M., Gavrilova, O., Everett, C., Reitman, M.L., Hudson, L.D., and Gonzalez, F.J. 2000. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol 20(14): 5119-5128.
  38. Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., and Schutz, G. 2001. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. Embo J 20(24): 7168-7173.
  39. Repa, J.J. and Mangelsdorf, D.J. 2000. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16: 459-481.
  40. Repa, J.J., Turley, S.D., Lobaccaro, J.A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R.A., Dietschy, J.M., and Mangelsdorf, D.J. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289(5484): 1524-1529.
  41. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. 1998. The peroxisome prolif-erator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391(6662): 79-82.
  42. Romert, A., Tuvendal, P., Simon, A., Dencker, L., and Eriksson, U. 1998. The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid. Proc Natl Acad Sci U S A 95(8): 4404-4409.
  43. Rosen, E.D., Sarraf, P., Troy, A.E., Bradwin, G., Moore, K., Milstone, D.S., Spiegelman, B.M., and Mortensen, R.M. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4(4): 611-617.
  44. Rowley, C.W., Staloch, L.J., Divine, J.K., McCaul, S.P., and Simon, T.C. 2006. Mechanisms of mutual functional interactions between HNF-4alpha and HNF-1alpha revealed by mutations that cause maturity onset diabetes of the young. Am J Physiol 290(3): G466-475.
  45. Ryffel, G.U. 2001. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 27(1): 11-29.
  46. Schoonjans, K., Watanabe, M., Suzuki, H., Mahfoudi, A., Krey, G., Wahli, W., Grimaldi, P., Staels, B., Yamamoto, T., and Auwerx, J. 1995. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 270(33): 19269-19276.
  47. Schuler, M., Ali, F., Chambon, C., Duteil, D., Bornert, J.M., Tardivel, A., Desvergne, B., Wahli, W., Chambon, P., and Metzger, D. 2006. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4(5): 407-414.
  48. Schwartz, K., Lawn, R.M., and Wade, D.P. 2000. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274(3): 794-802.
  49. Seol, W., Choi, H.S., and Moore, D.D. 1995. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 9(1): 72-85.
  50. Shaish, A., Harari, A., Hananshvili, L., Cohen, H., Bitzur, R., Luvish, T., Ulman, E., Golan, M., Ben-Amotz, A., Gavish, D., Rotstein, Z., and Harats, D. 2006. 9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients. Atherosclerosis 189(1): 215-221.
  51. Shih, S.J., Allan, C., Grehan, S., Tse, E., Moran, C., and Taylor, J.M. 2000. Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J Biol Chem 275(41): 31567-31572.
  52. Shin, H.D., Park, B.L., Kim, L.H., Jung, H.S., Cho, Y.M., Moon, M.K., Park, Y.J., Lee, H.K., and Park, K.S. 2004. Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity. Diabetes 53(3): 847-851.
  53. Sinal, C.J., Tohkin, M., Miyata, M., Ward, J.M., Lambert, G., and Gonzalez, F.J. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102(6): 731-744.
  54. Skogsberg, J., McMahon, A.D., Karpe, F., Hamsten, A., Packard, C.J., and Ehrenborg, E. 2003. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med 254(6): 597-604.
  55. Sladek, F. 2002. Desperately seeking...something. Mol Cell 10(2): 219-221.
  56. Sladek, F.M., Zhong, W.M., Lai, E., and Darnell, J.E., Jr. 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4(12B): 2353-2365.
  57. Sood, V., Colleran, K., and Burge, M.R. 2000. Thiazolidinediones: a comparative review of approved uses. Diabetes Technol Ther 2(3): 429-440.
  58. Spilianakis, C.G., Lee, G.R., and Flavell, R.A. 2005. Twisting the Th1/Th2 immune response via the retinoid X receptor: lessons from a genetic approach. Eur J Immunol 35(12): 3400-3404.
  59. Staudinger, J.L., Goodwin, B., Jones, S.A., Hawkins-Brown, D., MacKenzie, K.I., LaTour, A., Liu, Y., Klaassen, C.D., Brown, K.K., Reinhard, J., Willson, T.M., Koller, B.H., and Kliewer, S.A. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 98(6): 3369-3374.
  60. Stulnig, T.M., Steffensen, K.R., Gao, H., Reimers, M., Dahlman-Wright, K., Schuster, G.U., and Gustafsson, J.A. 2002. Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol 62(6): 1299-1305.
  61. Stunnenberg, H.G. 1993. Mechanisms of transactivation by retinoic acid receptors. Bioessays 15(5): 309-315.
  62. Sucov, H.M., Dyson, E., Gumeringer, C.L., Price, J., Chien, K.R., and Evans, R.M. 1994. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8(9): 1007-1018.
  63. Sueyoshi, T. and Negishi, M. 2001. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41: 123-143.
  64. Takeuchi, A., Reddy, G.S., Kobayashi, T., Okano, T., Park, J., and Sharma, S. 1998. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J Immunol 160(1): 209-218.
  65. Tamori, Y., Masugi, J., Nishino, N., and Kasuga, M. 2002. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51(7): 2045-2055.
  66. Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R.X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., and Sakai, J. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100(26): 15924-15929.
  67. Tangirala, R.K., Bischoff, E.D., Joseph, S.B., Wagner, B.L., Walczak, R., Laffitte, B.A., Daige, C.L., Thomas, D., Heyman, R.A., Mangelsdorf, D.J., Wang, X., Lusis, A.J., Tontonoz, P., and Schulman, I.G. 2002. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A 99(18): 11896-11901.
  68. Thompson, P.D., Remus, L.S., Hsieh, J.C., Jurutka, P.W., Whitfield, G.K., Galligan, M.A., Encinas Dominguez, C., Haussler, C.A., and Haussler, M.R. 2001. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J Mol Endocrinol 27(2): 211-227.
  69. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8(10): 1224-1234.
  70. Tontonoz, P. and Mangelsdorf, D.J. 2003. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17(6): 985-993.
  71. Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A., and Evans, R.M. 1998. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93(2): 241-252.
  72. Tribble, D.L., Holl, L.G., Wood, P.D., and Krauss, R.M. 1992. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93(3): 189-199.
  73. Veldman, C.M., Cantorna, M.T., and DeLuca, H.F. 2000. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374(2): 334-338.
  74. Venkateswaran, A., Laffitte, B.A., Joseph, S.B., Mak, P.A., Wilpitz, D.C., Edwards, P.A., and Tontonoz, P. 2000a. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 97(22): 12097-12102.
  75. Venkateswaran, A., Repa, J.J., Lobaccaro, J.M., Bronson, A., Mangelsdorf, D.J., and Edwards, P.A. 2000b. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 275(19): 14700-14707.
  76. Voors, A.W. and Johnson, W.D. 1979. Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. J Chronic Dis 32(1-2): 157-162.
  77. Vu-Dac, N., Schoonjans, K., Laine, B., Fruchart, J.C., Auwerx, J., and Staels, B. 1994. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 269(49): 31012-31018.
  78. Wallace, J.M., Schwarz, M., Coward, P., Houze, J., Sawyer, J.K., Kelley, K.L., Chai, A., and Rudel, L.L. 2005. Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys. J Lipid Res 46(5): 1009-1016.
  79. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J.M., Jeltsch, J.M., Staub, A., Jensen, E., Scrace, G., Waterfield, M., et al. 1985. Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A 82(23): 7889-7893.
  80. Wan, Y.J., An, D., Cai, Y., Repa, J.J., Hung-Po Chen, T., Flores, M., Postic, C., Magnuson, M.A., Chen, J., Chien, K.R., French, S., Mangelsdorf, D.J., and Sucov, H.M. 2000. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20(12): 4436-4444.
  81. Wang, H., Chen, J., Hollister, K., Sowers, L.C., and Forman, B.M. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3(5): 543-553.
  82. Wang, L., Lee, Y.K., Bundman, D., Han, Y., Thevananther, S., Kim, C.S., Chua, S.S., Wei, P., Heyman, R.A., Karin, M., and Moore, D.D. 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2(6): 721-731.
  83. Wang, X.D., Krinsky, N.I., Benotti, P.N., and Russell, R.M. 1994. Biosynthesis of 9-cis-retinoic acid from 9-cis-beta-carotene in human intestinal mucosa in vitro. Arch Biochem Biophys 313(1): 150-155.
  84. Wang, Y.X., Lee, C.H., Tiep, S., Yu, R.T., Ham, J., Kang, H., and Evans, R.M. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113(2): 159-170.
  85. Wang, Y.X., Zhang, C.L., Yu, R.T., Cho, H.K., Nelson, M.C., Bayuga-Ocampo, C.R., Ham, J., Kang, H., and Evans, R.M. 2004. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2(10): E294.
  86. Weinberger, C., Hollenberg, S.M., Ong, E.S., Harmon, J.M., Brower, S.T., Cidlowski, J., Thompson, E.B., Rosenfeld, M.G., and Evans, R.M. 1985. Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228(4700): 740-742.
  87. Weinshilboum, R.M., Otterness, D.M., Aksoy, I.A., Wood, T.C., Her, C., and Raftogianis, R.B. 1997. Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. Faseb J 11(1): 3-14.
  88. Wolfrum, C., Borrmann, C.M., Borchers, T., and Spener, F. 2001. Fatty acids and hypolipi-demic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci U S A 98(5): 2323-2328.
  89. Xie, M.H., Holcomb, I., Deuel, B., Dowd, P., Huang, A., Vagts, A., Foster, J., Liang, J., Brush, J., Gu, Q., Hillan, K., Goddard, A., and Gurney, A.L. 1999. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11(10): 729-735.
  90. Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C.M., Nelson, M.C., Ong, E.S., Waxman, D.J., and Evans, R.M. 2001. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A 98(6): 3375-3380.
  91. Yoshikawa, T., Shimano, H., Yahagi, N., Ide, T., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Tomita, S., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Takahashi, A., Sone, H., Osuga Ji, J., Gotoda, T., Ishibashi, S., and Yamada, N. 2002. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277(3): 1705-1711.
  92. Yu, L., Hammer, R.E., Li-Hawkins, J., Von Bergmann, K., Lutjohann, D., Cohen, J.C., and Hobbs, H.H. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 99(25): 16237-16242.
  93. Zhang, Y., Lee, F.Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F.J., Willson, T.M., and Edwards, P.A. 2006. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A 103(4): 1006-1011.
  94. Zhang, Y., Repa, J.J., Gauthier, K., and Mangelsdorf, D.J. 2001. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem 276(46): 43018-43024.
  95. Zollner, G., Marschall, H.U., Wagner, M., and Trauner, M. 2006. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3(3): 231-251.
Delicious Diabetic Recipes

Delicious Diabetic Recipes

This brilliant guide will teach you how to cook all those delicious recipes for people who have diabetes.

Get My Free Ebook


Post a comment